Search bioRxivSearch

bioRxiv · 10.1101/748210

Approximate Bayesian computation of transcriptional pausing mechanisms

Abstract

At a transcriptional pause site, RNA polymerase (RNAP) takes significantly longer than average to transcribe the nucleotide before moving on to the next position. At the single-molecule level this process is stochastic, while at the ensemble level it plays a variety of important roles in biological systems. The pause signal is complex and invokes interplay between a range of mechanisms. Among these factors are: non-canonical transcription events - such as backtracking and hypertranslocation; the catalytically inactive intermediate state hypothesised to act as a precursor to backtracking; the energetic configuration of basepairing within the DNA/RNA hybrid and of those flanking the transcription bubble; and the structure of the nascent mRNA. There are a variety of plausible models and hypotheses but it is unclear which explanations are better.\n\nWe performed a systematic comparison of 128 kinetic models of transcription using approximate Bayesian computation. Under this Bayesian framework, models and their parameters were assessed by their ability to predict the locations of pause sites in the E. coli genome.\n\nThese results suggest that the structural parameters governing the transcription bubble, and the dynamics of the transcription bubble during translocation, play significant roles in pausing. This is consistent with a model where the relative Gibbs energies between the pre and posttranslocated positions, and the rate of translocation between the two, is the primary factor behind invoking transcriptional pausing. Whereas, hypertranslocation, backtracking, and the intermediate state are not required to predict the locations of transcriptional pause sites. Finally, we compared the predictive power of these kinetic models to that of a non-explanatory statistical model. The latter approach has significantly greater predictive power (AUC = 0.89 cf. 0.73), suggesting that, while current models of transcription contain a moderate degree of predictive power, a much greater quantitative understanding of transcriptional pausing is required to rival that of a sequence motif.\n\nAuthor summaryTranscription involves the copying of a DNA template into messenger RNA (mRNA). This reaction is implemented by RNA polymerase (RNAP) successively incorporating nucleotides onto the mRNA. At a transcriptional pause site, RNAP takes significantly longer than average to incorporate the nucleotide. A model which can not only predict the locations of pause sites in a DNA template, but also explain how or why they are pause sites, is sought after.\n\nTranscriptional pausing emerges from cooperation between several mechanisms. These mechanisms include non-canonical RNAP reactions; and the thermodynamic properties of DNA and mRNA. There are many hypotheses and kinetic models of transcription but it is unclear which hypotheses and models are required to predict and explain transcriptional pausing.\n\nWe have developed a rigorous statistical framework for inferring model parameters and comparing hypotheses. By applying this framework to published pause-site data, we compared 128 kinetic models of transcription with the aim of finding the best models for predicting the locations of pause sites. This analysis offered insights into mechanisms of transcriptional pausing. However, the predictive power of these models lacks compared with non-explanatory statistical models - suggesting the data contains more information than can be satisfied by current quantitative understandings of transcriptional pausing.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Douglas, J., Kingston, R. L., Drummond, A. J.. 2019-08-28. Approximate Bayesian computation of transcriptional pausing mechanisms. https://doi.org/10.1101/748210

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology